GrabAGun Q1 2026: Firearms Sales Surge 10.5% YoY, Outpacing Industry

What happened

GrabAGun reported Q1 2026 revenue driven by a 10.5% year-over-year increase in firearms sales, significantly outpacing the 1.6% rise in adjusted NICS background checks, indicating continued market share gains. The company maintains a strong balance sheet with $109.5 million in cash and no debt, though GAAP profitability remains pressured by public company costs and stock-based compensation. This performance supports the thesis that the core e-commerce operation is gaining traction despite a flat industry backdrop, and that EBITDA normalization remains achievable as listing expenses roll off. The key catalyst is whether management can sustain this growth trajectory while controlling G&A to return to pre-SPAC profitability levels. The stock still trades near cash value, implying the market is pricing in significant skepticism about the operating business.

Implication

For investors, the Q1 results confirm that GrabAGun is executing on market share gains, with firearms sales growth handily beating the industry. The challenge remains translating top-line momentum into profitability: G&A and stock-based compensation are still dragging on earnings. The balance sheet provides a cushion, but the stock's valuation near cash suggests the market is not yet crediting the operating improvement. A disciplined approach is warranted—wait for evidence of EBITDA breakeven or positive free cash flow before adding aggressively. The attractive entry point remains, but investors should monitor cash burn and any M&A that could dilute value.

Thesis delta

The Q1 results reinforce the thesis of market share gains and operational momentum, but the path to profitability remains the critical missing piece. There is no material shift; the investment case continues to rest on the assumption that public company costs will fade and EBITDA will normalize, a bet that is now slightly better-supported by the revenue outperformance. However, the lack of profit improvement in the quarter keeps the thesis in the 'prove it' stage.